Pharmacokinetics, pharmacodynamics and tolerability of single escalating doses of SAR 302503 in male volunteers
Latest Information Update: 15 Sep 2015
At a glance
- Drugs Fedratinib (Primary)
- Indications Myelofibrosis
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Sanofi
- 25 Apr 2013 New trial record
- 10 Apr 2013 Results presented at the 104th Annual Meeting of the American Association for Cancer Research.